Research projects typically involve
- Poorly water-soluble and BCS class 2 drug delivery using nanotechnology
- Biopharmaceuticals, peptides, and large molecules drug delivery using nanotechnology,
- Physicochemical characterization of formulations,
- in vitro cellular testing of drugs and formulations (safety, activity, and proof of concept)
- With potential collaborations on in vivo conceptualization and synthesis of ligands for drug targeting.
We collaborate widely with research groups in academia, industry, and research institutes.
Public outreach & key achievements
Liposomes, lipid nanocapsules and smartCrystals®: a comparative study for an effective
quercetin delivery to the skin
Hatahet T., Morel Mr., Hommoss A., Devoisselle JM., Müller R. H., Bégu S.
International Journal of Pharmaceutics 542 (2018) 176–185
Molybdenum cluster loaded PLGA nanoparticles: An innovative theranostic approach
for the treatment of ovarian cancer
Brandhonneur N., Hatahet T., Amela-Cortes Mr., Molard Y., Cordier S., Dollo G.
European Journal of Pharmaceutics and Biopharmaceutics 125 (2018) 95–105
Quercetin topical application: from conventional dosage forms toward nanodosage Forms
Hatahet T., Morel Mr., Hommoss A. Devoisselle, J.M., Müller, R.H., Bégu S.
European Journal of Pharmaceutics and Biopharmaceutics 108 (2016) 41-53,
Dermal quercetin smartCrystals®: formulation development, antioxidant activity and cellular safety.
Hatahet, T., Morel, M., Hommoss, A., Dorandeu, C., Müller, R. H., Bégu, S.
European Journal of Pharmaceutics and Biopharmaceutics 102 (2016) 51-63,
|PhD Title||Development of nano- immunomodulator for skin cancer|
|Year of Study||1|
Alumni: Where are they now